Opto Circuits (India) is currently trading at Rs. 10.85, up by 0.64 points or 6.27% from its previous closing of Rs. 10.21 on the BSE.
The scrip opened at Rs. 10.85 and has touched a high and low of Rs. 11.23 and Rs. 10.65 respectively. So far 6,74,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 11.75 on 29-Nov-2017 and a 52 week low of Rs. 6.84 on 05-Oct-2017.
Last one week high and low of the scrip stood at Rs. 11.23 and Rs. 9.27 respectively. The current market cap of the company is Rs. 311.93 crore.
The promoters holding in the company stood at 21.53%, while Institutions and Non-Institutions held 1.74% and 76.73% respectively.
Opto Circuits (India) -- wholly owned subsidiary -- Eurocor GmbH, an international leader in vascular devices, has acquired patent application related to bioresorbable stents.
Bioresorbable stents represent a novel alternative to traditional vascular stent technology. This novel stent design uses a material combination of metal and polymer which combines the advantage of bioresorbable and robust stent properties. The patent grant will bolster the extension of Eurocor product portfolio to include bioresorbable devices, capable of addressing significant new markets and customers globally.
Opto Circuits (India) designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.